Two signature, must-attend sessions will close out the 2025 San Antonio Breast Cancer Symposium^® on Friday, December 12.

SABCS^® Co-Directors Carlos Arteaga, MD, and Virginia Kaklamani, MD, will lead an expert panel in discussing the most important breast cancer research of 2025 during Year in Review, from 3 to 5 p.m. CT in the Stars at Night Ballroom 1-2 at the Henry B. Gonzalez Convention Center. This comprehensive review session will feature the following themes and panelists:

• Basic Research: Steffi Oesterreich, PhD, Co-Director of the Women’s Cancer Research Center and Professor and Shear Family Foundation Chair for Breast Cancer Research at the University of Pittsburgh School of Medicine
• Translational Research: Frederick M. Howard, MD, Medical Oncologist and Assistant Professor of Medicine at the University of Chicago
• Early Breast Cancer: William Gradishar, MD, Betsy Bramsen Professor of Breast Oncology and Director of the Maggie Daley Center for Women’s Cancer Care at Robert H. Lurie Comprehensive Cancer Center of Northwestern University
• Metastatic Breast Cancer: Sonya A. Reid, MD, MPH, Assistant Professor of Medicine and Assistant Director of Community Outreach and Engagement at Vanderbilt University Medical Center

Following the program, attendees can reset during a reception break outside of the ballroom from 5 to 5:30 p.m.

View From the Trenches: What to Do on Monday Morning will continue in Stars at Night Ballroom 1-2 from 5:30 to 6:30 p.m. This lively panel discussion will examine how attendees can bridge SABCS 2025 scientific presentations and patient care. It will be a distillation of the most actionable information from this year’s symposium, said Session Moderator Heather L. McArthur, MD, MPH, Professor and Komen Distinguished Chair in Clinical Breast Cancer Research at UT Southwestern.

“The View From the Trenches session has been a centerpiece of SABCS over the years largely because it effectively translates the groundbreaking research that’s presented during the course of the meeting into practical, clinical applications from multiple perspectives,” Dr. McArthur said.

“We will go through a sort of rapid-fire review of the high-impact presentations from the past days, approach them from a multidisciplinary perspective and from the perspective of a patient advocate, and present some recommendations for attendees to take away with them and apply in their work when they return to their clinics on Monday morning.”

Five experts will join Dr. McArthur for this session, each representing a different discipline, and all participating in the open, back-and-forth format:

• Surgical Oncology: Judy C. Boughey, MD, Chair of Breast and Melanoma Surgical Oncology at Mayo Clinic
• Radiation Oncology: Jonathan B. Strauss, MD, MBA, Vice Chair of Operations of Radiation Oncology and Professor at Feinberg School of Medicine, Northwestern University
• Medical Oncology: Lajos Pusztai, MD, DPhil, Professor of Medicine at Yale School of Medicine and Co-Leader of Genetics, Genomics, and Epigenetics at Yale Cancer Center; and Komal L. Jhaveri, MD, Patricia and James Cayne Chair for Junior Faculty, Section Head of the Endocrine Therapy Research Program, and Clinical Director of the Early Drug Development Service at Memorial Sloan Kettering Cancer Center
• Patient Advocacy: Julia Maués, Co-Founder, GRASP Cancer

“This is a great opportunity to see key opinion leaders who are shaping their independent fields come together, engage in this important conversation, and review a lot of high-level data that has taken place in a short time,” Dr. McArthur said.

“The session has also been popular because it allows you to hear an immediate patient perspective,” she added. “Sometimes that patient perspective on the data has been different, and often it has really affected the conversation. Data is one thing, but the voice of someone who could be sitting in front of you in the clinic can be particularly powerful.”